cytogenetics | GenomeWeb

cytogenetics

NEW YORK (GenomeWeb) – CombiMatrix is developing two new tests that will expand its place in the reproductive health market, one of which will complement existing chromosomal microarray analysis services and the other of which will open CombiMatrix up to a new market segment.

NEW YORK (GenomeWeb News) – CombiMatrix today announced a 13 percent spike in first quarter revenues, driven by a 34 percent jump in sales generated by its prenatal chromosomal microarray analysis testing services.

NEW YORK (GenomeWeb) – PerkinElmer will continue to sell microarrays and software developed by Signature Genomics, despite its decision to shutter the company's laboratory services business.

NEW YORK (GenomeWeb) – PerkinElmer has decided to close its Signature Genomics cytogenetic testing services business.

NEW YORK (GenomeWeb) - While chromosomal microarray analysis has become the first-tier cytogenetic test for diagnosing individuals with constitutional abnormalities around the world, geneticists continue to struggle with a high level of findings of unknown significance.

Affymetrix has provided more information about how it achieved US Food and Drug Administration clearance for its CytoScan Dx Assay chromosomal microarray analysis offering.

Chromosomal microarray analysis may be widely regarded as a first-tier method for both pediatric and prenatal cytogenetic testing, but that hasn't convinced some insurers to reimburse such tests.

NEW YORK (GenomeWeb News) – Two forms of a rare subgroup of acute lymphoblastic leukemia form through chromothripsis, or catastrophic chromosome shattering, researchers from the Wellcome Trust S

The discovery of variants of unknown significance during a prenatal chromosomal microarray analysis can create headaches for genetic counselors who are used to delivering certain results to patients, according to the authors of a recent paper.

Oxford Gene Technology this week announced that it has acquired Cytocell, a supplier of probes for fluorescence in situ hybridization experiments.

Pages

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.